epidem
infect
predict
occur
larg
unpredict
time
place
microb
consequ
follow
highlight
recent
epidem
record
surpris
categori
list
could
continu
almost
indefinit
point
epidem
domain
infecti
diseas
public
health
expect
manag
prevent
outbreak
requir
detect
report
isol
case
manag
list
includ
divers
pathogen
lifethreaten
diseas
infect
import
public
health
implic
upsurg
pediatr
infect
adult
mani
travelrel
infect
multipl
public
health
threat
continu
concern
influenza
foodborn
diseas
valu
antibiot
seem
obviou
first
patient
receiv
penicillin
young
woman
streptococc
bacteremia
fever
daili
week
receiv
penicillin
intraven
start
march
promptli
recov
surviv
age
year
would
appear
evidencebas
medicin
n
follow
statement
dr
walsh
mcdermott
summar
breakthrough
especi
well
penicillin
gave
cur
power
barefoot
itiner
care
provid
deepest
reach
africa
collect
power
physician
new
york
citi
recent
experi
bacteri
resist
spars
pipelin
threaten
miracl
antivir
develop
quit
differ
primarili
hiv
hepat
c
viru
hcv
appear
patient
hiv
achiev
nearnorm
longev
hcv
infect
even
impress
term
speed
progress
abil
cure
hcv
treatment
stori
reflect
effici
basic
scienc
defin
target
pharmaceut
skill
industri
wellorgan
trial
network
regulatori
agenc
us
food
drug
administr
fda
facilit
product
develop
impact
vaccin
also
impress
comparison
annual
incid
diseas
unit
state
report
period
prior
avail
design
vaccin
compar
incid
show
decreas
polio
diphtheria
rubella
mump
invas
type
b
haemophilu
influenza
pertussi
disappoint
recent
report
conclud
global
total
live
save
vaccin
exce
million
impact
could
substanti
greater
global
access
fewer
refus
better
pertussi
vaccin
recent
cdc
analysi
annual
cost
associ
major
nosocomi
infect
total
billion
per
year
unit
state
follow
rank
order
median
costcas
central
line
bacteremia
ventilatorassoci
pneumonia
surgic
site
infect
clostridium
difficil
infect
catheterassoci
urinari
tract
infect
illustr
challeng
prioriti
anoth
challeng
epidem
involv
nosocomi
pathogen
shown
klebsiella
pneumonia
carbapenemaseproduc
bacteria
kpc
nation
institut
health
nih
clinic
center
began
patient
transfer
new
york
citi
hospit
kpc
infect
becam
sourc
institut
outbreak
requir
extraordinari
effort
control
includ
wall
construct
isol
case
remov
plumb
possibl
sourc
use
matrixassist
laser
desorptionion
timeofflight
malditof
molecular
diagnost
detect
case
carrier
hydrogen
peroxid
room
aerosol
whole
hous
surveil
cultur
epidem
final
halt
toll
case
fatal
month
anoth
kpc
epidemiolog
investig
show
widespread
distribut
microb
longterm
acutecar
facil
chicago
area
other
demonstr
distribut
kpc
air
travel
india
europ
epidem
requir
extens
resourc
special
skill
expect
increas
substanti
era
bad
bug
avian
influenza
rabi
first
surviv
without
vaccin
west
nile
viru
bioterror
transfusionassoci
jacobcreutzfeldt
diseas
strain
methicillinresist
staphylococcu
aureu
mrsa
sar
chlamydia
pneumonia
role
coronari
arteri
diseas
influenza
carbapenemaseproduc
gramneg
bacilli
colistin
constant
infus
antibiot
molecular
diagnost
litani
epidem
new
pathogen
mimiviru
borrelia
miyamotoi
emmonsia
speci
bradyrhizobium
enterica
c
difficil
gene
sequenc
microbiom
hcv
note
interv
result
complet
new
agenda
consid
time
import
field
base
rapid
chang
topic
microb
new
epidem
new
diagnost
new
antimicrobi
imposs
predict
menu
known
gene
resist
antimicrobi
agent
well
establish
bacteria
least
million
year
evid
human
life
use
antibiot
select
gene
mendelian
law
make
increasingli
difficult
control
previous
treatabl
infect
problem
predict
father
antibiot
alexand
fleme
wrote
public
demand
drug
begin
era
abus
microb
educ
resist
penicillin
host
penicillinfast
organ
bred
pass
anoth
individu
perhap
other
reach
someon
get
septicemia
pneumonia
penicillin
save
case
thoughtless
person
play
penicillin
treatment
moral
respons
death
man
final
succumb
infect
penicillinresist
organ
hope
evil
avert
also
note
predict
nobel
laureat
joshua
lederberg
futur
human
microb
like
evolv
episod
wit
vs
gene
appear
fleme
predict
harsh
realiti
evolutionari
microbi
resist
gene
gain
upper
hand
reflect
combin
massiv
antibiot
use
lack
new
pharmacolog
agent
result
alarm
escal
antibiot
resist
global
appli
nearli
categori
treatabl
pathogen
lead
predict
postantibiot
era
resist
declar
crisi
infecti
diseas
societi
america
cdc
us
congress
us
presid
disturb
observ
unit
state
conspicu
absenc
nation
plan
deal
resist
includ
lack
live
record
antibiot
consumpt
resist
correl
locat
trajectori
sharp
contrast
european
union
includ
countri
offici
languag
divers
cultur
systemat
collect
data
antibiot
consumpt
microbi
resist
pattern
year
result
multipl
public
data
review
studi
intervent
messag
consum
ebug
internet
program
student
european
antibiot
awar
day
standard
method
collect
data
recent
plan
budget
address
issu
data
strike
show
dramat
associ
per
capita
antibiot
use
nation
resist
pattern
exampl
antibiot
consumpt
greec
nearli
time
netherland
expect
resist
problem
greec
magnitud
differ
alarm
bacterem
carbapenemas
strain
among
bacterem
k
pneumonia
isol
appear
time
common
greec
mrsa
percentag
aureu
isol
time
higher
european
union
appear
matur
substant
model
learn
import
caveat
function
well
claim
ownership
equal
partner
also
good
nation
program
success
address
specif
problem
learn
exampl
given
base
nation
data
address
major
challeng
impress
result
unit
state
remain
unansw
challeng
also
opportun
skill
infecti
diseas
disciplin
term
data
collect
evalu
intervent
trial
polici
implement
practic
primarili
form
antibiot
stewardship
recent
report
use
gene
sequenc
suggest
convent
method
infect
control
could
substanti
improv
effort
exampl
result
unit
kingdom
larg
disproven
convent
teach
regard
epidemiolog
c
difficil
infect
technolog
also
appear
contradict
contemporari
concept
transmiss
pattern
aureu
proven
valuabl
tool
outbreak
investig
kpc
infect
hospit
larg
commun
outbreak
kpc
involv
multipl
facil
seem
clear
technolog
get
faster
cheaper
embrac
infect
control
standard
although
need
caution
skill
interpret
result
work
develop
countri
anoth
attract
career
option
base
need
probabl
impact
uniqu
special
program
presid
emerg
plan
aid
relief
bill
melinda
gate
foundat
other
direct
patient
care
possibl
attract
target
impact
develop
implement
innov
program
deal
vast
need
combin
minim
resourc
new
healthcar
system
valu
infecti
diseas
expertis
base
import
role
address
resist
cost
associ
nosocomi
infect
nevertheless
fear
current
structur
payment
system
construct
good
fit
priorit
infecti
diseas
skill
specif
code
prevent
infect
conserv
antibiot
use
prevent
resist
pathogen
might
erron
conclus
situat
may
chang
system
matur
becom
seriou
address
crisi
bundl
deal
healthcar
effici
vogu
could
strength
infecti
diseas
exampl
central
line
bacteremia
prevent
bundl
prove
effect
trial
gener
adopt
bundl
predict
save
live
billion
per
year
us
hospit
subsequ
action
clinician
regulatori
agenc
stakehold
result
estim
declin
central
line
bacteremia
rate
special
skill
manag
studi
infecti
diseas
increasingli
import
specialti
contemporari
medicin
role
practition
disciplin
divers
usual
import
sometim
critic
commonli
undervalu
contemporari
prioriti
healthcar
system
healthcar
reform
would
difficult
find
anoth
disciplin
medicin
extraordinari
divers
surpris
valu
patient
care
clinic
relev
domest
intern
applic
mani
train
medicin
join
field
infecti
diseas
simpli
right
thing
